Status:
RECRUITING
Long-Covid-19 Alleviation Through Learning Mindfulness Study
Lead Sponsor:
Columbia University
Conditions:
Long COVID
Long Covid19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This research is being done to study a mindfulness intervention among people who have symptoms of Post-Acute Sequelae of SARS-CoV-2 infection (PASC), also known as Long COVID. Mindfulness is defined a...
Detailed Description
Patients with COVID-19 disease who go on to develop Post-Acute Sequelae of SARS-CoV-2 infection (PASC) are under significant physical and psychosocial stress. Mindfulness, operationally defined as pay...
Eligibility Criteria
Inclusion
- Age \> or = 18
- Willing and able to provide informed consent
- Access to the internet
- Self-reported history of SARS-CoV-2 infection
- Current symptoms attributed to PASC by participant or by participant's medical provider; ongoing symptoms that persisted \>= 12 weeks after Covid-19 illness
Exclusion
- Participating in another clinical trial of an intervention for PASC symptoms
- Engaged in a structured MBI
Key Trial Info
Start Date :
May 21 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 21 2027
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT07140094
Start Date
May 21 2024
End Date
November 21 2027
Last Update
August 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University
New York, New York, United States, 10032